Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer

● Auf Lager

Katalog-Nr.::VE009372
CAS-Nr.::N/A
Summenformel::C24H31ClN2O4
Molare Masse::447.00 g/mol

Zusätzliche Informationen zu Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer

Parent drug

Cetirizine

IUPAC-Name

1-Hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate compound with 2-hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate (1:1)

Synonyme

N/A

SMILES

O=C(OCC(O)C)COCCN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1

InChI

InChI=1S/C24H31ClN2O4/c1-19(28)17-31-23(29)18-30-16-15-26-11-13-27(14-12-26)24(20-5-3-2-4-6-20)21-7-9-22(25)10-8-21/h2-10,19,24,28H,11-18H2,1H3

Beschreibung

Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer standard is a well-characterized compound that aligns with key regulatory guidelines, including USP, EMA, JP, and BP. It plays a crucial role in analytical method development, method validation (AMV), and quality control (QC) processes, particularly in the manufacturing of Cetirizine. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), ensuring reliable and precise analytical outcomes. A mixture of Propylene Glycol Ester Of Cetrizine Diastereomer or 1-Hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazine-1-yl)ethoxy)acetate compound with 2-hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazine-1-yl)ethoxy)acetate (1:1), is a selective Histamine-1 antagonist, it is used in the treatment sneezing, coughing, nasal congestion, the active metabolite of the piperazine H1-receptor antagonist hydroxyzine, the volume of distribution: 0.44 and plasma protein binding is 93%.

References

Naqvi, Aasim, and Valerie Gerriets. “Cetirizine.” Nih.gov, StatPearls Publishing, 27 Nov. 2021, www.ncbi.nlm.nih.gov/books/NBK549776/. ‌

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url